Drugs / tegafur,gimeracil and oteracil porassium
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07178340 | Sep 2025 → Sep 2027 expected | hepatoid adenocarcinoma | Peking University Cancer Hospital & Institute | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tegafur,gimeracil and oteracil porassium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07178340 ↗ |